Why Karyopharm Therapeutics Inched Higher Today
The companys second-quarter performance had some highlights, but investors might have been concerned about full-year guidance....…
Börse:
5,408€
2,08%
Echtzeit-Aktienkurs Karyopharm Therapeutics
Bid:
5,395€
Ask:
5,421€
Nachrichtenticker der Karyopharm Therapeutics Aktie
Why Karyopharm Therapeutics Inched Higher Today
The companys second-quarter performance had some highlights, but investors might have been concerned about full-year guidance....
Den vollständigen Artikel können Sie lesen unter: https://www.fool.com/investing/2022/08/04/why-karyopharm-therapeutics-inched-higher-today/?source=iedfolrf0000001.
Den vollständigen Artikel können Sie lesen unter: https://www.fool.com/investing/2022/08/04/why-karyopharm-therapeutics-inched-higher-today/?source=iedfolrf0000001.